Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

266
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
266
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

11.0K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.0K
Decision Making01:20

Decision Making

107
Decision-making is a fundamental cognitive process that involves evaluating alternatives and selecting among them. This process can range from simple choices, such as deciding what to wear, to complex decisions, like choosing a major in college or a career path. The complexity of the decision often dictates the approach we use, which can be broadly categorized into two types: automatic and controlled decision-making.
Automatic decision-making is fast, intuitive, and relies on gut feelings...
107
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

85
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
85

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-effectiveness of Pharmacist- and Nurse Practitioner-led Medication Management for Heart Failure With Reduced Ejection Fraction.

The Canadian journal of cardiology·2026
Same author

Association of ischaemic stroke/TIA with subsequent oral anticoagulant adherence in patients with atrial fibrillation: a scoping review.

BMJ open·2026
Same author

Oral anticoagulant switching in patients with atrial fibrillation: a long-term cohort study using population-level administrative data.

International journal of clinical pharmacy·2026
Same author

Characterizing Antithrombotic Regimens After Isolated Mitral Valve Repair: A Retrospective Descriptive Study and Interview of Cardiac Surgeons.

The American journal of cardiology·2026
Same author

Heart Failure Guideline-Directed Medical Therapy Scoring Systems: A Scoping Review.

Circulation. Heart failure·2026
Same author

Author Correction to "Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology, Volume 41, Issue 10, Pages 1857-1874. DOI: 10.1016/j.cjca.2025.07.027]".

The Canadian journal of cardiology·2026

Related Experiment Video

Updated: Jun 26, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K

Shared decision-making approach to type 2 diabetes management.

Blair J MacDonald1, James P McCormack2, Ricky D Turgeon3

  • 1Doctoral candidate in the Faculty of Pharmaceutical Sciences at the University of British Columbia in Vancouver.

Canadian Family Physician Medecin De Famille Canadien
|May 14, 2024
PubMed
Summary
This summary is machine-generated.

A new decision aid helps patients with type 2 diabetes mellitus (T2DM) make informed medication choices. It personalizes risks and compares treatment benefits and harms, supporting shared decision-making for better health outcomes.

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.8K
Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

1.7K

Related Experiment Videos

Last Updated: Jun 26, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.8K
Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

1.7K

Area of Science:

  • Endocrinology and Metabolism
  • Health Informatics
  • Patient Decision Aids

Background:

  • Type 2 diabetes mellitus (T2DM) affects millions, increasing risks of mortality and cardiovascular/microvascular complications.
  • Numerous medication options exist for T2DM, complicating treatment decisions due to patient-specific preferences and outcomes.
  • Shared decision-making is crucial for individualizing T2DM treatment but has been hindered by complexity.

Purpose of the Study:

  • To develop and provide an online interactive decision aid for shared decision-making regarding T2DM medication choices.
  • To empower patients with T2DM to make autonomous and informed treatment decisions.

Main Methods:

  • Systematic review of guidelines, clinical databases (DynaMed, UpToDate), and PubMed for prediction models and pharmacotherapeutic options.
  • Searched for meta-analyses and randomized controlled trials to determine benefits and harms of T2DM treatments.
  • Developed the PEER Diabetes Medication Decision Aid, incorporating personalized risk estimates and treatment comparisons.

Main Results:

  • The decision aid provides personalized 10-year risk estimates for six key diabetes-related outcomes.
  • Patients can prioritize outcomes and compare benefits/harms of up to 12 treatments.
  • Information is presented in absolute numbers, including practical factors like cost.

Conclusions:

  • The PEER Diabetes Medication Decision Aid is a practical tool for patients with T2DM.
  • It facilitates autonomous and well-informed medication choices, enhancing patient engagement in their care.